from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3703c/-

LFCtreatmentdescriptionclass of inhibitor

-0.065

Amikacinug/mL Amikacintranslation

-1.276

Cap5-10ug/mL Capreomycintranslation

-2.403

Rox10-50 ug/mL Roxithromycintranslation

-0.042

SM2-5 ug/mL Streptomycintranslation

-3.243

Tet5-10 ug/mL Tetracyclinetranslation

0.667

Rif0.2-5ug/mL Rifampicintranscription

0.257

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.756

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.425

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.094

CPZ10-50 ug/mL Chlorpromazinerespiration

0.557

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.034

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.843

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.118

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.155

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.277

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.799

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.277

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.674

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.122

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.622

KCN5-20 ug/mL Potassium cyaniderespiration

-0.932

NaN30.2-2 mM Sodium aziderespiration

-0.943

Nigericin50 uM Nigericinrespiration

-0.273

TRC10-150 ug/mL Triclosanrespiration

-0.148

TRZ10-25 ug/mL Thioridazinerespiration

-1.812

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.602

menadione6-10 ug/mL Menadionerespiration

0.391

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.346

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.011

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.239

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.950

NRP_1Non-replicating persistence stage 1dosRassociated

0.128

Amp0.2mg/mL AmpicillincellWall

0.100

Cephalexin20-100 ug/mL CephalexincellWall

-0.351

Cerulenin0.32-5 ug/mL CerulenincellWall

0.173

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.451

EMB10-20 ug/mL EthambutolcellWall

0.694

Eta12-40 ug/mL EthionamidecellWall

0.767

INH0.2-0.4 ug/mL IsoniazidcellWall

0.357

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.286

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.172

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.036

BZA0.12 mg/mL BenzamidearomaticAmides

-0.094

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.638

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.670

H2O24 mM hydrogen peroxideDNAdamaging

-0.091

Levo10 ug/mL LevofloxacinDNAdamaging

-0.293

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.391

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.481

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.027

UVUV-irradiationDNAdamaging

0.057

ARP41-4 ug/mL Antitubercular compound ARP4?

0.238

Antimycin12.5-50 ug/mL Antimycin A?

-0.472

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.488

PA_110-50 ug/mL Antitubercular compound PA-1?

0.291

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.211

PA8240.2-2 ug/mL PA-824?

0.359

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.482

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.381

Verapamil50 uM Verapamil?

-0.333

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.348

methoxatin10-20 ug/mL Methoxatin?